The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Agendia; Amgen; AstraZeneca; Celgene; Clovis Oncology; Eisai; Genomic Health; Gilead Sciences; GlaxoSmithKline; Immunomedics (Inst); Lilly; MSD Oncology; Myriad Genetics; Novartis; Pfizer; PharmaMar; Pierre Fabre; Roche/Genentech; Seagen; Tesaro
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); CureVac; Eisai; Genomic Health; Gilead Sciences; GlaxoSmithKline; Immunomedics (Inst); Pfizer; Roche (Inst); Tesaro; Vaccibody (Inst)
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Tesaro (Inst); Vaccibody (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
A randomized phase II trial of mirvetuximab soravtansine (IMGN853), in folate receptor alpha (FRα)-high recurrent ovarian cancer eligible for platinum-based chemotherapy.
 
Fabian Trillsch
Honoraria - AstraZeneca; Clovis Oncology; Eisai; Gedeon Richter; MSD Oncology; Roche; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; Eisai Germany; MSD Oncology; Roche; Tesaro/GSK
Research Funding - AstraZeneca (Inst); Roche (Inst); Tesaro/GSK
Travel, Accommodations, Expenses - AstraZeneca; Tesaro/GSK
 
Fabienne Schochter
Honoraria - AstraZeneca; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Roche
Expert Testimony - GlaxoSmithKline
 
Tjoung-Won Park-Simon
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis; Pfizer; Roche; Seagen; Tesaro
Consulting or Advisory Role - AstraZeneca; Eisai; Exact sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Seagen; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Alexander Reuss
No Relationships to Disclose
 
Tanja N. Fehm
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; MSD Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Roche
 
Pauline Wimberger
Honoraria - Amgen; AstraZeneca; Eisai; MSD Oncology; Novartis/Pfizer; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Novartis; PharmaMar; Roche Pharma AG; Tesaro
Travel, Accommodations, Expenses - Roche Pharma AG
 
Holger Bronger
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline/Tesaro; Roche
Consulting or Advisory Role - GlaxoSmithKline; Roche
Speakers' Bureau - AstraZeneca; GlaxoSmithKline
 
Barbara Schmalfeldt
Honoraria - AstraZeneca; Clovis Oncology; F. Hoffmann LaRoche; GlaxoSmithKline; MSD; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche; Tesaro
Research Funding - AstraZeneca; Clovis Oncology; F. Hoffmann LaRoche; GlaxoSmithKline; MSD; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; F. Hoffmann LaRoche; Tesaro
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
 
Frederik Marmé
No Relationships to Disclose
 
Florian Heitz
Honoraria - AstraZeneca; Clovis Oncology; F. Hoffmann LaRoche; GlaxoSmithKline; Novocure; PharmaMar
Consulting or Advisory Role - Amedes; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Novocure; PharmaMar; Roche
Research Funding - AstraZeneca; F. Hoffmann LaRoche
 
Sven Mahner
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Michaela Fredrich
No Relationships to Disclose
 
Stefanie Barth
No Relationships to Disclose
 
James Joseph Stec
Employment - ImmunoGen
Stock and Other Ownership Interests - ImmunoGen
Travel, Accommodations, Expenses - ImmunoGen
 
Michael W. Method
Employment - Immunogen
Stock and Other Ownership Interests - Exact Sciences; Lilly
 
Philipp Harter
Honoraria - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Lilly; MSD Oncology; Roche; Sotio; Stryker; Zai Lab
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Merck; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Roche (Inst)